For the third year in a row, UCLA and the Pacific Heart, Lung and Blood Institute of Los Angeles organized a symposium focused on lung-sparing therapies for patients dealing with difficult-to-treat malignant pleural mesothelioma (MPM).
According to a press release by the institute, this year’s symposium – held in mid May – centered on therapies designed to preserve vital lung function.
The symposium…